RESEARCH PAPER
Trends in baseline CD4 count at presentation to care among HIV-positive patients in Sungai Buloh Hospital, Malaysia
1
Department of Medicine, Sungai Buloh Hospital, Malaysia
Submission date: 2018-09-30
Acceptance date: 2019-04-19
Publication date: 2019-07-11
HIV & AIDS Review 2019;18(2):85-91
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Many people living with human immunodeficiency virus (HIV) do not enter healthcare until late in their infection course. We analysed the trends in baseline CD4 count among HIV patients in Sungai Buloh Hospital, Malaysia.
Material and methods:
A retrospective cohort study was conducted from the Malaysian AIDS Treatment Cohort (MATCH) database of HIV-positive patients registered in our HIV clinic between 2007 and 2016.
Results:
Out of 8757 patients, 84.5% were male. Heterosexual (38.2%) and homosexual (36.4%) contacts were the predominant HIV risk factors. Approximately 44% of patients presented late to care (CD4 < 200 cells/µl). The overall median baseline CD4 cell count was 235 cells/µl. The yearly median baseline CD4 cell count increased steadily from 176 cells/µl in 1997 to a peak of 271 cells/µl in 2015 (p for trend < 0.001). By HIV exposure risks, homosexual risk group consistently had the highest median baseline CD4 cell count, followed by heterosexual and intravenous drug use (IVDU) risk groups. The proportion of late presenters significantly decreased over time from 57.0% in 2007 to 44.0% in 2016 (p for trend < 0.001).
Conclusions:
The trends in baseline CD4 cell counts are improving, but the proportion of late presenters is still significant. Innovative strategies are imperative to identify HIV infected individuals early and link them promptly to HIV care.
Many people living with human immunodeficiency virus (HIV) do not enter healthcare until late in their infection course. We analysed the trends in baseline CD4 count among HIV patients in Sungai Buloh Hospital, Malaysia.
Material and methods:
A retrospective cohort study was conducted from the Malaysian AIDS Treatment Cohort (MATCH) database of HIV-positive patients registered in our HIV clinic between 2007 and 2016.
Results:
Out of 8757 patients, 84.5% were male. Heterosexual (38.2%) and homosexual (36.4%) contacts were the predominant HIV risk factors. Approximately 44% of patients presented late to care (CD4 < 200 cells/µl). The overall median baseline CD4 cell count was 235 cells/µl. The yearly median baseline CD4 cell count increased steadily from 176 cells/µl in 1997 to a peak of 271 cells/µl in 2015 (p for trend < 0.001). By HIV exposure risks, homosexual risk group consistently had the highest median baseline CD4 cell count, followed by heterosexual and intravenous drug use (IVDU) risk groups. The proportion of late presenters significantly decreased over time from 57.0% in 2007 to 44.0% in 2016 (p for trend < 0.001).
Conclusions:
The trends in baseline CD4 cell counts are improving, but the proportion of late presenters is still significant. Innovative strategies are imperative to identify HIV infected individuals early and link them promptly to HIV care.
REFERENCES (32)
1.
Yamashita TE, Phair JP, Munoz A, et al. Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study. AIDS 2001; 15: 735-746.
2.
Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
4.
Castilla J, Sobrino P, De La Fuente L, et al. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002; 16: 1945-1951.
5.
Chadborn T, Delpech V, Sabin CA, et al. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). AIDS 2006; 20: 2371-2379.
6.
Chadborn TR, Baster K, Delpech VC, et al. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002). AIDS 2005; 19: 513-520.
7.
Gupta SB, Gilbert RL, Brady AR, et al., on behalf of the CDSSAG. CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990-1998. AIDS 2000; 14: 853-861.
8.
Girardi E, Aloisi MS, Arici C, et al., ICoNA Behavioural Epidemiology Study Group. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004; 36: 951-959.
9.
Couturier E, Schwoebel V, Michon C, et al. Determinants of delayed diagnosis of HIV infection in France, 1993-1995. AIDS 1998; 12: 795-800.
10.
Samet JH, Retondo MJ, Freedberg KA, et al. Factors associated with initiation of primary medical care for HIV-infected persons. Am J Med 1994; 97: 347-353.
11.
Girardi E, Sampaolesi A, Gentile M, et al. Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 25: 71-76.
12.
Mugavero MJ, Castellano C, Edelman D, Hicks C. Late diagnosis of HIV infection: the role of age and sex. Am J Med 2007; 120: 370-373.
13.
Schwarcz S, Hsu L, Dilley JW, et al. Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS. J Acquir Immune Defic Syndr 2006; 43: 491-494.
14.
McDonald AM, Li Y, Dore GJ, et al. Late HIV presentation among AIDS cases in Australia, 1992-2001. Aust N Z J Public Health 2003; 27: 608-613.
15.
Samet JH, Freedberg KA, Stein MD, et al. Trillion Virion Delay: Time from testing positive for HIV to presentation for primary care. Arch Intern Med 1998; 158: 734.
16.
Gay CL, Napravnik S, Eron JJ Jr. Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors. AIDS 2006; 20: 775-778.
17.
Gardner LI Jr, Brundage JF, McNeil JG, et al. Predictors of HIV-1 disease progression in early-and late stage patients: the U.S. Army Natural History Cohort. Military Medical Consortium for Applied Retrovirology. J Acquir Immune Defic Syndr 1992; 5: 782-793.
18.
Girardi E, Sabin CA, Monforte AD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007; 46 Suppl 1: S3-S8.
19.
Hocking JS, Rodger AJ, Rhodes DG, Crofts N. Late presentation of HIV infection associated with prolonged survival following AIDS diagnosis – characteristics of individuals. Int J STD AIDS 2000; 11: 503-508.
20.
Lanoy E, Mary-Krause M, Tattevin P, et al. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 2007; 12: 89-96.
21.
Masson CL, Sorensen JL, Phibbs CS, Okin RL. Predictors of medical service utilization among individuals with co-occurring HIV infection and substance abuse disorders. AIDS Care 2004; 16: 744-755.
22.
Samet JH, Freedberg KA, Savetsky JB, et al. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS 2001; 15: 77-85.
23.
Samji H, Cescon A, Hogg RS, et al. North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8: e81355.
24.
The Insight Start Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med 2015; 373: 795-807.
25.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Second Edition. 2016.
28.
Lesko CR, Cole SR, Zinski A, et al. A systematic review and meta-regression of temporal trends in adult CD4 cell count at presentation to HIV care, 1992-2011. Clin Infect Dis 2013; 57: 1027-1037.
29.
Singh D, Chawarski MC, Schottenfeld R, Vicknasingam B. Substance abuse and the HIV situation in Malaysia. J Food Drug Anal 2013; 21: S46-S51.
31.
Diaz A, del Romero J, Rodriguez C, et al., for the EPI-VIH Study Group. Effects of region of birth, educational level and age on late presentation among men who have sex with men newly diagnosed with HIV in a network of STI/HIV counselling and testing clinics in Spain. Euro Surveill 2015; 20: 21088.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
